These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 16219898)
1. Natalizumab for the treatment of multiple sclerosis and Crohn's disease. Keeley KA; Rivey MP; Allington DR Ann Pharmacother; 2005 Nov; 39(11):1833-43. PubMed ID: 16219898 [TBL] [Abstract][Full Text] [Related]
2. Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn's disease. Ko HH; Bressler B Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):29-39. PubMed ID: 19072431 [TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of natalizumab for formulary consideration. Bivins A; Hou K; Ayesu N; Ellsworth B; Montenegro S; Tu X; Boyle C; Dowling T; Shaya FT Expert Opin Biol Ther; 2010 Aug; 10(8):1279-87. PubMed ID: 20626228 [TBL] [Abstract][Full Text] [Related]
4. Natalizumab for induction of remission in Crohn's disease. Macdonald JK; McDonald JW Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112 [TBL] [Abstract][Full Text] [Related]
5. The role of natalizumab in the treatment of multiple sclerosis. Coyle PK Am J Manag Care; 2010 Jun; 16(6 Suppl):S164-70. PubMed ID: 20615052 [TBL] [Abstract][Full Text] [Related]
7. Natalizumab for induction of remission in Crohn's disease. MacDonald JK; McDonald JW Cochrane Database Syst Rev; 2007 Jan; (1):CD006097. PubMed ID: 17253580 [TBL] [Abstract][Full Text] [Related]
8. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Goodin DS; Cohen BA; O'Connor P; Kappos L; Stevens JC; Neurology; 2008 Sep; 71(10):766-73. PubMed ID: 18765653 [TBL] [Abstract][Full Text] [Related]
12. [Natalizumab in the treatment of multiple sclerosis]. Horga A; Horga de la Parte JF Rev Neurol; 2007 Sep 1-15; 45(5):293-303. PubMed ID: 17876741 [TBL] [Abstract][Full Text] [Related]
13. Recommendations for the selection, treatment, and management of patients utilizing natalizumab therapy for multiple sclerosis. Foley J Am J Manag Care; 2010 Jun; 16(6 Suppl):S178-83. PubMed ID: 20615054 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of natalizumab for multiple sclerosis and Crohn's disease: a meta analysis]. Li YY; Li YP; Sun X; Wang L; Wen J; Cheng L Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Oct; 32(5):533-42. PubMed ID: 21050557 [TBL] [Abstract][Full Text] [Related]
18. Natalizumab for the treatment of Crohn's disease. Bickston SJ; Muniyappa K Expert Rev Clin Immunol; 2010 Jul; 6(4):513-9. PubMed ID: 20594122 [TBL] [Abstract][Full Text] [Related]